Concepedia

Xingxiang Xu

XX

19

Publications

1.1K

Citations

15

H-Index

2001

Active since

Affiliations

Northern Jiangsu People's Hospital(Current)

Jiangsu Province Hospital

Zhejiang University

Central South University

First Affiliated Hospital of Zhengzhou University

Xingxiang Xu is an author at Northern Jiangsu People's Hospital specializing in medicine, oncology, and tumor biology.

Top concepts

Publications per year

2001–2023

19

Publications

19

Camrelizumab Plus Carboplatin and Paclitaxel as First-Line Treatment for Advanced Squamous NSCLC (CameL-Sq): A Phase 3 Trial

Shengxiang Ren, Jianhua Chen, Xingxiang Xu et al. · Journal of Thoracic Oncology · 2021 · 293 citations

, , +8

Efficacy of Aumolertinib (HS-10296) in Patients With Advanced EGFR T790M+ NSCLC: Updated Post-National Medical Products Administration Approval Results From the APOLLO Registrational Trial

Shun Lü, Qiming Wang, Guojun Zhang et al. · Journal of Thoracic Oncology · 2021 · 137 citations · Full text

Diminished expression of S100A2, a putative tumor suppressor, at early stage of human lung carcinogenesis.

Guoying Feng, Xingxiang Xu, E.M. Youssef et al. · PubMed · 2001 · 120 citations

, , +20

miRNA-148a serves as a prognostic factor and suppresses migration and invasion through Wnt1 in non-small cell lung cancer

Yong Chen, Lingfeng Min, Chuanli Ren et al. · PLoS ONE · 2017 · 108 citations · Full text

, , +15

miRNA-200c increases the sensitivity of breast cancer cells to doxorubicin through the suppression of E-cadherin-mediated PTEN/Akt signaling

Yong Chen, Ying Sun, Longbang Chen et al. · Molecular Medicine Reports · 2013 · 89 citations · Full text

, , +11

Rows per page

1–5 of 19